Diabetes Fonds Report issue

Foundation

Organization Overview

First Clinical Trial
2014
NCT02129595
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

resveratrol (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1